Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Complex Dermatological Case Studies in Oncology
Description
In this presentation from MD Anderson, the speaker discusses complex dermatological case studies in oncology, highlighting two primary cases involving patients with unique skin reactions related to their cancer therapies. The first case involves a 50-year-old man with recurrent thymoma who developed Sweet Syndrome, presenting tender lesions and fever after chemotherapy. A biopsy confirmed the diagnosis, and treatment with prednisone led to a rapid resolution of symptoms and allowed the patient to continue his cancer therapy uninterrupted. The second case features a 41-year-old woman with lupus and non-healing ulcers, diagnosed as pyoderma gangrenosum, requiring careful management due to her complex medical history. Despite challenges related to inadequate healthcare access, her condition improved after systemic steroid treatment and consults with various specialists. This presentation emphasizes the importance of timely biopsies, collaboration among medical professionals, and adaptable treatment strategies to address the dermatological complications cancer patients may face as a result of their therapies, underscoring the dermatology department's pivotal role in oncology care.
View moreConclusions
- Prompt diagnosis and treatment of skin conditions in cancer patients is crucial to maintaining their complex therapeutic regimens.
- Sweet syndrome, a rare inflammatory dermatosis, can be effectively managed with systemic corticosteroids, evidenced by rapid resolution of symptoms in case presentations.
- In cases of pyoderma gangrenosum, timely intervention with immunosuppressive therapy, such as prednisone and infliximab, is essential for promoting wound healing and preventing deterioration.
- Interdisciplinary collaboration is vital for managing complicated skin issues in oncology patients to address multiple comorbidities and ensure comprehensive care.
- Dapsone demonstrates efficacy in managing skin adverse effects associated with cancer therapies, providing a potential avenue for improving patient quality of life.
- Lesions in oncology patients often present atypically, making it critical to rule out infection and consider biopsy for accurate diagnosis.
- Utilization of the PARACELSUS score aids in diagnosing pyoderma gangrenosum by systematically evaluating clinical features and exclusion of differential diagnoses.
- F. Jockenhöfer, U. Wollina, K.A. Salva, S. Benson, J. Dissemond. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum* Department of Dermatology, Venereology and Allergology and Institute of Medical Psychology and Behavioral Immunobiology, University Hospital of Essen, Germany. Department of Dermatology and Allergology, Academic Teaching Hospital Dresden, Germany. Linked Editorial: Schreml. Br J Dermatol 2019; 180:438-439. PMID: 29388188
- Sophie H. Guenin, MSc, Saakshi Khattri, MD, Mark G. Lebwohl, MD. CASE REPORT: Spesolimab use in treatment of pyoderma gangrenosum.